“A YEAR OF CHANGE
The healthcare industry is constantly being reshaped by M&A activity, and 2021 was no exception.”
“Some of the year’s largest healthcare M&A deals – Blackstone and Carlyle’s $30B+ Medline buyout, Microsoft’s $19B+ Nuance buy, Datavant’s $7B merger with Ciox Health, and Humana’s $5B+ acquisition of Kindred – provide a snapshot of where the industry might be going next.”
“From optimizing supply chains in the wake of COVID (Medline), to finding new ways to bring AI and advanced analytics to healthcare (Nuance, Kindred), to shifting priorities and preferences in care delivery (Kindred), these larger deals are emblematic of trends that cut across the healthcare world.”
“While the commercial healthcare sector may receive the lion’s share of capital flows and corresponding attention, deal activity in the public sector can’t go unnoticed.”
“And for companies that serve public sector customers, transactions have major import on not only capabilities, but also on customer and contract vehicle access, partner/competitor relationships, and customer buying behavior.”
“When a handful of contract wins can make or break a strategic vision, it can pay to buy in – at the right place, right time, and right price.”
“MAJOR HEALTHCARE M&A DEALS IN THE PUBLIC SECTOR
2021 gave us a mix of pure-play healthcare deals and diversified federal service acquisitions. To name a handful of notable healthcare M&A transactions…” Read the full article here.
Source: What 2021 Tells Us About Public Sector Healthcare M&A in 2022 and Beyond – By Alexander Cobb and Rachel Jenkins, May 3, 2022. Avascent Group.
